hepatocellular carcinoma
Conditions
Interventions
Interventional treatment group:NA
Sponsors
Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Typical imaging features of hepatocellular carcinoma, elevated AFP or pathological diagnosis of hepatocellular carcinoma; (2) At least two imaging assessments based on enhanced CT or enhanced MR Before surgery or interventional treatment, and the target lesions can be measured according to RECIST1.1/mRECIST criteria; (3) At least one evaluation of blood tumor markers, liver function and blood routine before treatment; (4) At least one imaging evaluation based on contrast-enhanced CT or contrast-enhanced MR After interventional therapy, which should be completed within 2 months after immunotherapy, and the target lesions can be measured according to ECIST1.1/mRECIST criteria; (5) Received at least one interventional therapy, including TACE, HAIC, TIPS, or PTCD; (6) At least one DSA data was available. (7) Patients who underwent surgical treatment had complete pathological data.
Exclusion criteria
Exclusion criteria: (1) Severe renal impairment and intolerance to contrast media; (2) History of congenital or acquired immune deficiency (such as HIV infection); (3) History of other malignant tumors in the past 3 years or at the same time; (4) History of organ transplantation; (5) Loss of clinical information or follow-up data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall remission; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Countries
China
Contacts
Public ContactFei Gao
Sun Yat-sen University Cancer Center
Outcome results
None listed